(6R)-6-butyl-6-[(1S)-2-[tert-butyl(diphenyl)silyl]oxy-1-triethylsilyloxyethyl]oxan-2-one
C33H52O4Si2 — CID 134974933
Data last refreshed: (MolForge compound catalog, from PubChem)
About (6R)-6-butyl-6-[(1S)-2-[tert-butyl(diphenyl)silyl]oxy-1-triethylsilyloxyethyl]oxan-2-one
(6R)-6-butyl-6-[(1S)-2-[tert-butyl(diphenyl)silyl]oxy-1-triethylsilyloxyethyl]oxan-2-one (PubChem CID 134974933) has the molecular formula C33H52O4Si2 and a molecular weight of 568.95 g/mol. Its IUPAC name is (6R)-6-butyl-6-[(1S)-2-[tert-butyl(diphenyl)silyl]oxy-1-triethylsilyloxyethyl]oxan-2-one.
Molecular Properties
| Compound Name | (6R)-6-butyl-6-[(1S)-2-[tert-butyl(diphenyl)silyl]oxy-1-triethylsilyloxyethyl]oxan-2-one |
|---|---|
| PubChem CID | 134974933 |
| Molecular Formula | C33H52O4Si2 |
| Molecular Weight | 568.95 g/mol |
| Exact Mass | 568.34 |
| IUPAC Name | (6R)-6-butyl-6-[(1S)-2-[tert-butyl(diphenyl)silyl]oxy-1-triethylsilyloxyethyl]oxan-2-one |
| SMILES | CCCC[C@]1([C@H](CO[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)O[Si](CC)(CC)CC)CCCC(=O)O1 |
| InChI | InChI=1S/C33H52O4Si2/c1-8-12-25-33(26-19-24-31(34)36-33)30(37-38(9-2,10-3)11-4)27-35-39(32(5,6)7,28-20-15-13-16-21-28)29-22-17-14-18-23-29/h13-18,20-23,30H,8-12,19,24-27H2,1-7H3/t30-,33+/m0/s1 |
| InChIKey | HFASATHOQXOSSL-BZKUTMRRSA-N |
| XLogP | 7.61 |
| TPSA | 44.76 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 568.95 |
| LogP ≤ 5 | 7.61 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134974933 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.